Top

Published in:

01-05-2021 | Affective Disorder | Review

Increased risk of mental health disorders in patients with RA during the COVID-19 pandemic: a possible surge and solutions

Authors: Ansh Bhatia, Manish KC, Latika Gupta

Published in: Rheumatology International | Issue 5/2021

Abstract

Depression is a common co-morbidity among rheumatoid arthritis (RA) patients, which may translate into difficulty performing activities of daily living. COVID-19 is an unprecedented disaster that has disrupted lives worldwide and led to a rise in the incidence of mental health disorders. Given the widespread economic devastation due to COVID-19, many RA patients, already susceptible to mental illness, maybe at an increased risk of inaccessibility to medical care, accentuated stress, and consequent worsening of existent mental health disorders, or the onset of new mental health disorders such as anxiety, post-traumatic stress disorder, or depression. The objective of this review is to assess if there is an increased risk of mental health disorders in patients with RA during the COVID-19 pandemic. Telemedicine has bridged the transition to remote chronic care in the pandemic period, though certain accessibility and technological challenges are to be addressed. Decreased access to care amid lockdowns and a proposed triggering of disease activity in patients with autoimmune disorders may potentially herald a massive spike in incidence or flares of patients diagnosed with RA in the coming months. Such a deluge of cases may be potentially devastating to an overburdened healthcare system. Rheumatologists may need to prepare for this eventuality and explore techniques to provide adequate care during these challenging times. The authors found that there is a significant association between the adverse impact on the mental health of RA patients and the COVID-19 pandemic. However, more research is needed to highlight individual risk factors.

Census of India: Area And Population. https://censusindia.gov.in/census_and_you/area_and_population.aspx. Accessed 8 Jan 2021

Dickens C, McGowan L, Clark-Carter D, Creed F (2002) Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis. Psychosom Med 64:52–60CrossRefPubMed

Wright GE, Parker JC, Smarr KL et al (1998) Age, depressive symptoms, and rheumatoid arthritis. Arthritis Rheum 41:298–305. https://doi.org/10.1002/1529-0131(199802)41:2%3C298::AID-ART14%3E3.0.CO;2-GCrossRefPubMed

Abdel-Nasser AM, Abd El-Azim S, Taal E et al (1998) Depression and depressive symptoms in rheumatoid arthritis patients: an analysis of their occurrence and determinants. Rheumatology 37:391–397. https://doi.org/10.1093/rheumatology/37.4.391CrossRef

Isik A, Koca SS, Ozturk A et al (2007) Anxiety and depression in patients with rheumatoid arthritis. ClinRheumatol 26:872–878. https://doi.org/10.1007/s10067-006-0407-yCrossRef

Shortage of rheumatologists in India: Experts | Hyderabad News - Times of India. In: Times India. https://timesofindia.indiatimes.com/city/hyderabad/shortage-of-rheumatologists-in-india-experts/articleshow/78629034.cms. Accessed 11 Jan 2021

Poll: Many Americans feel lonely and anxious during pandemic. (2020) In: AP NEWS. https://apnews.com/article/48019472e2c7fdfa2d1718bd63592f4b. Accessed 4 Jan 2021

Matcham F, Rayner L, Steer S, Hotopf M (2013) The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. RheumatolOxfEngl 52:2136–2148. https://doi.org/10.1093/rheumatology/ket169CrossRef

Margaretten M, Yelin E, Imboden J et al (2009) Predictors of depression in a multiethnic cohort of patients with rheumatoid arthritis. Arthritis Rheum 61:1586–1591. https://doi.org/10.1002/art.24822CrossRefPubMedPubMedCentral

10.

O’Connor RC, Wetherall K, Cleare S et al (2020) Mental health and well-being during the COVID-19 pandemic: longitudinal analyses of adults in the UK COVID-19 Mental Health & Wellbeing study. Br J Psychiatry. https://doi.org/10.1192/bjp.2020.212CrossRefPubMedPubMedCentral

11.

Cleaton N, Raizada S, Barkham N, et al (2020) COVID-19 prevalence and the impact on quality of life from stringent social distancing in a single large UK rheumatology centre. Annals of the Rheumatic Diseases. Published Online First: 21 July 2020. https://doi.org/10.1136/annrheumdis-2020-218236. Accessed 13 Jan 2021

12.

Chudasama YV, Gillies CL, Zaccardi F et al (2020) Impact of COVID-19 on routine care for chronic diseases: A global survey of views from healthcare professionals. Diabetes MetabSyndr 14:965–967. https://doi.org/10.1016/j.dsx.2020.06.042CrossRef

13.

Ziadé N, el Kibbi L, Hmamouchi I et al (2020) Impact of the COVID-19 pandemic on patients with chronic rheumatic diseases: a study in 15 Arab countries. Int J Rheum Dis 23:1550–1557. https://doi.org/10.1111/1756-185X.13960CrossRefPubMed

14.

Seyahi E, Poyraz BC, Sut N et al (2020) The psychological state and changes in the routine of the patients with rheumatic diseases during the coronavirus disease (COVID-19) outbreak in Turkey: a web-based cross-sectional survey. RheumatolInt 40:1229–1238. https://doi.org/10.1007/s00296-020-04626-0CrossRef

15.

Ji J, Zhang L, Zhang Q et al (2017) Functional disability associated with disease and quality-of-life parameters in Chinese patients with rheumatoid arthritis. Health Qual Life Outcomes 15:89. https://doi.org/10.1186/s12955-017-0659-zCrossRefPubMedPubMedCentral

16.

Mukherjee D, Lahiry S, Sinha R (2017) Association of depression in rheumatoid arthritis: a single centre experience. Int J Res Med Sci 5:3600–3604. https://doi.org/10.18203/2320-6012.ijrms20173570

17.

Wilson JM, Lee J, Fitzgerald HN et al (2020) Job insecurity and financial concern during the COVID-19 pandemic are associated with worse mental health. J Occup Environ Med 62:686–691. https://doi.org/10.1097/JOM.0000000000001962CrossRefPubMed

18.

Verstappen SMM (2015) Rheumatoid arthritis and work: the impact of rheumatoid arthritis on absenteeism and presenteeism. Best Pract Res ClinRheumatol 29:495–511. https://doi.org/10.1016/j.berh.2015.06.001CrossRef

19.

Endstrasser F, Braito M, Linser M et al (2020) The negative impact of the COVID-19 lockdown on pain and physical function in patients with end-stage hip or knee osteoarthritis. Knee Surg Sports TraumatolArthrosc 28:2435–2443. https://doi.org/10.1007/s00167-020-06104-3CrossRef

20.

Brown TS, Bedard NA, Rojas EO et al (2020) The effect of the COVID-19 pandemic on electively scheduled hip and knee arthroplasty patients in the United States. J Arthroplasty 35:S49–S55. https://doi.org/10.1016/j.arth.2020.04.052CrossRefPubMedPubMedCentral

21.

Matcham F, Ali S, Irving K et al (2016) Are depression and anxiety associated with disease activity in rheumatoid arthritis? A prospective study BMC prospective study. BMC MusculoskeletDisord 17:155. https://doi.org/10.1186/s12891-016-1011-1CrossRef

22.

Bai B, Chen M, Fu L et al (2020) Quality of life and influencing factors of patients with rheumatoid arthritis in Northeast China. Health Qual Life Outcomes 18:119. https://doi.org/10.1186/s12955-020-01355-7CrossRefPubMedPubMedCentral

23.

Kojima M, Kojima T, Suzuki S et al (2009) Depression, inflammation, and pain in patients with rheumatoid arthritis. Arthritis Care Res 61:1018–1024. https://doi.org/10.1002/art.24647CrossRef

24.

Matcham F, Ali S, Hotopf M, Chalder T (2015) Psychological correlates of fatigue in rheumatoid arthritis: a systematic review. ClinPsychol Rev 39:16–29. https://doi.org/10.1016/j.cpr.2015.03.004CrossRef

25.

Ang DC, Choi H, Kroenke K, Wolfe F (2005) Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis. J Rheumatol 32:1013–1019 (PMID: 15940760)PubMed

26.

Boyden SD, Hossain IN, Wohlfahrt A, Lee YC (2016) Non-inflammatory causes of pain in patients with rheumatoid arthritis. CurrRheumatol Rep 18:30. https://doi.org/10.1007/s11926-016-0581-0CrossRef

27.

Ramiro S, Radner H, van der Heijde D et al (2011) Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis). Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD008886.pub2CrossRefPubMed

28.

Whittle SL, Richards BL, Husni E, Buchbinder R (2011) Opioid therapy for treating rheumatoid arthritis pain. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD003113.pub3CrossRefPubMed

29.

Kojima M, Kojima T, Suzuki S et al (2014) Alexithymia, depression, inflammation, and pain in patients with rheumatoid arthritis. Arthritis Care Res 66:679–686. https://doi.org/10.1002/acr.22203CrossRef

30.

Baumeister H, Balke K, Härter M (2005) Psychiatric and somatic comorbidities are negatively associated with quality of life in physically ill patients. J ClinEpidemiol 58:1090–1100. https://doi.org/10.1016/j.jclinepi.2005.03.011CrossRef

31.

DiMatteo MR, Lepper HS, Croghan TW (2000) Depression Is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 160:2101. https://doi.org/10.1001/archinte.160.14.2101CrossRefPubMed

32.

Pratt LA, Brody DJ (2010) Depression and smoking in the U.S. household population aged 20 and over, 2005–2008. NCHS Data Brief 1–8. PMID: 20604991

33.

Curtis R, Groarke A, Coughlan R, Gsel A (2004) The influence of disease severity, perceived stress, social support and coping in patients with chronic illness: a 1 year follow up. Psychol Health Med 9:456–475. https://doi.org/10.1080/1354850042000267058CrossRef

34.

Evers A, Kraaimaat F, Geenen R, Jacobs J, Bijlsma J (2003) Pain coping and social support as predictors of long-term functional disability and pain in early rheumatoid arthritis. Behav Res Ther 41:1295–1310. https://doi.org/10.1016/S0005-7967(03)00036-6CrossRefPubMed

35.

Morris A, Yelin EH, Wong B, Katz PP (2008) Patterns of psychosocial risk and long-term outcomes in rheumatoid arthritis. Psychol Health Med 13:529–544. https://doi.org/10.1080/13548500801927113CrossRefPubMedPubMedCentral

36.

Curtis R, Groarke A, Coughlan R, Gsel A (2005) Psychological stress as a predictor of psychological adjustment and health status in patients with rheumatoid arthritis. Patient EducCouns 59:192–198. https://doi.org/10.1016/j.pec.2004.10.015CrossRef

37.

McBain H, Shipley M, Newman S (2013) The impact of appearance concerns on depression and anxiety in rheumatoid arthritis. Musculoskeletal Care 11:19–30. https://doi.org/10.1002/msc.1020CrossRefPubMed

38.

Dekkers JC, Geenen R, Evers AWM et al (2001) Biopsychosocial mediators and moderators of stress–health relationships in patients with recently diagnosed rheumatoid arthritis. Arthritis Care Res 45:307–316. https://doi.org/10.1002/1529-0131(200108)45:4%3c307::AID-ART342%3e3.0.CO;2-0CrossRef

39.

Strating MMH, Suurmeijer TPBM, Schuur WHV (2006) Disability, social support, and distress in rheumatoid arthritis: results from a thirteen-year prospective study. Arthritis Care Res 55:736–744. https://doi.org/10.1002/art.22231CrossRef

40.

Bonfá E, Gossec L, Isenberg DA et al (2021) How COVID-19 is changing rheumatology clinical practice. Nat Rev Rheumatol 17:11–15. https://doi.org/10.1038/s41584-020-00527-5CrossRefPubMed

41.

Naveen R, Sundaram TG, Agarwal V, Gupta L (2021) Teleconsultation experience with the idiopathic inflammatory myopathies: a prospective observational cohort study during the COVID-19 pandemic. RheumatolInt 41:67–76. https://doi.org/10.1007/s00296-020-04737-8CrossRef

42.

Gupta L, Lilleker JB, Agarwal V et al (2020) COVID-19 and myositis – unique challenges for patients. Rheumatology. https://doi.org/10.1093/rheumatology/keaa610CrossRefPubMedPubMedCentral

43.

Gupta L, Kharbanda R, Agarwal V et al (2021) Patient perspectives on the effect of the SARS-CoV-2 pandemic on patients with systemic sclerosis: an international patient survey. JCR J ClinRheumatol 27:31–33. https://doi.org/10.1097/RHU.0000000000001681CrossRef

44.

Gupta L, Misra DP, Agarwal V, et al (2020) Response to: ‘Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort’ by Costa et al. Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2020-217953

45.

Currie CL, Larouche R, Voss ML et al (2020) The impact of eHealth group interventions on the mental, behavioral, and physical health of adults: a systematic review protocol. Syst Rev 9:217. https://doi.org/10.1186/s13643-020-01479-3CrossRefPubMedPubMedCentral

46.

Misra DP, Agarwal V (2020) To act or to wait for the evidence: ethics in the time of covid-19! Indian J Rheumatol 15:3–4. https://doi.org/10.4103/injr.injr_53_20CrossRef

47.

Ahmed S, Gasparyan AY, Zimba O (2021) Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic. RheumatolInt. https://doi.org/10.1007/s00296-020-04764-5CrossRef

48.

Lin EHB, Katon W, Von Korff M et al (2003) Effect of improving depression care on pain and functional outcomes among older adults with arthritis: a randomized controlled trial. JAMA 290:2428. https://doi.org/10.1001/jama.290.18.2428CrossRefPubMed

49.

T S, R G, J.a.p JJWG and DS (2014) Psychological Factors Associated with Response to Treatment in Rheumatoid Arthritis. In: Curr. Pharm. Des. https://www.eurekaselect.com/124107/article. Accessed 13 Jan 2021

50.

Goel A, Gupta L (2020) Social media in the times of COVID-19. JCR J ClinRheumatol 26:220–223. https://doi.org/10.1097/RHU.0000000000001508CrossRef

51.

Brady SM, Fenton SAM, Metsios GS et al (2021) Different types of physical activity are positively associated with indicators of mental health and psychological wellbeing in rheumatoid arthritis during COVID-19. RheumatolInt 41:335–344. https://doi.org/10.1007/s00296-020-04751-wCrossRef

52.

van Zanten JJCSV, Fenton SAM, Brady S, et al (2020) Mental health and psychological wellbeing in rheumatoid arthritis during COVID-19 – can physical activity help? Mediterr J Rheumatol 31:284. https://doi.org/10.31138/mjr.31.3.284

53.

Agarwal V, Sharma S, Gupta L et al (2020) COVID-19 and psychological disaster preparedness – an unmet need. Disaster Med Public Health Prep 14:387–390. https://doi.org/10.1017/dmp.2020.219CrossRefPubMed

54.

Geenen R, Overman CL, Christensen R et al (2018) EULAR recommendations for the health professional’s approach to pain management in inflammatory arthritis and osteoarthritis. Ann Rheum Dis 77:797–807. https://doi.org/10.1136/annrheumdis-2017-212662CrossRefPubMed

55.

Richards BL, Whittle SL, Buchbinder R (2012) Muscle relaxants for pain management in rheumatoid arthritis. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD008922.pub2CrossRefPubMedPubMedCentral

56.

American Geriatrics Society (2019) Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am GeriatrSoc 67:674–694. https://doi.org/10.1111/jgs.15767CrossRef

57.

Ruhaila AR, Chong HC (2018) Self-reported symptoms of depression, anxiety and stress among patients with rheumatoid arthritis in a Malaysian rheumatology centre - prevalence and correlates. Med J Malaysia 73:226–232 (PMID: 30121685)PubMed

58.

Vallerand IA, Lewinson RT, Frolkis AD et al (2018) Depression as a risk factor for the development of rheumatoid arthritis: a population-based cohort study. RMD Open 4:e000670. https://doi.org/10.1136/rmdopen-2018-000670CrossRefPubMedPubMedCentral

59.

Marrie RA, Walld R, Bolton JM et al (2017) Increased incidence of psychiatric disorders in immune-mediated inflammatory disease. J Psychosom Res 101:17–23. https://doi.org/10.1016/j.jpsychores.2017.07.015CrossRefPubMed

60.

Marrie RA, Walld R, Bolton JM et al (2018) Psychiatric comorbidity increases mortality in immune-mediated inflammatory diseases. Gen Hosp Psychiatry 53:65–72. https://doi.org/10.1016/j.genhosppsych.2018.06.001CrossRefPubMed

61.

Gåfvels C, Hägerström M, Rane K et al (2016) Depression and anxiety after 2 years of follow-up in patients diagnosed with diabetes or rheumatoid arthritis. Health Psychol Open 3:2055102916678107. https://doi.org/10.1177/2055102916678107CrossRefPubMedPubMedCentral

62.

Demmelmaier I, Pettersson S, Nordgren B et al (2018) Associations between fatigue and physical capacity in people moderately affected by rheumatoid arthritis. RheumatolInt 38:2147–2155. https://doi.org/10.1007/s00296-018-4140-zCrossRef

63.

Wang SL, Chang CH, Hu LY, Tsai SJ, Yang AC, You Z-H (2014) Risk of developing depressive disorders following rheumatoid arthritis: a nationwide population-based study. PLoS ONE 9:e107791. https://doi.org/10.1371/journal.pone.0107791CrossRefPubMedPubMedCentral

Title: Increased risk of mental health disorders in patients with RA during the COVID-19 pandemic: a possible surge and solutions
Authors: Ansh Bhatia
Manish KC
Latika Gupta
Publication date: 01-05-2021
Publisher: Springer Berlin Heidelberg
Keywords: Affective Disorder
Arthritis
Affective Disorder
COVID-19
Rheumatoid Arthritis
Telemedicine
Published in: Rheumatology International / Issue 5/2021
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-021-04829-z

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Increased risk of mental health disorders in patients with RA during the COVID-19 pandemic: a possible surge and solutions

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2021

Primary central nervous system lymphoma in neuropsychiatric systemic lupus erythematosus: case-based review

Targeted high concentration botulinum toxin A injections in patients with Raynaud’s phenomenon: a retrospective single-centre experience

Cross-cultural adaptation and psychometric testing of the Dutch and German versions of the Evaluation of Daily Activity Questionnaire in people with rheumatoid arthritis

Lung cancer mimicking systemic lupus erythematosus: case-based review

Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience

Multiple system inflammatory syndrome associated with SARS-CoV-2 infection in an adult and an adolescent

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page